2D Chemical StructureDatabase ID 131637883
No renderable structure data available
SMILES
C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)CC=C([C@H]([C@H](C=CC=C4CO[C@H]\5[C@@]4([C@@H](C=C(/C5=N\O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)C)O[C@@H]1C8CCCCC8Structure data verified · Database ID 131637883
Chemical Intermediate
4'-O-2,6-Dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl Selamectin
CAS 301849-46-7Product ID 724943
| Intermediates | 4'-O-2,6-Dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl Selamectin |
|---|---|
| IUPAC Name | — |
| CAS Number | 301849-46-7 |
| Database ID | 131637883 |
| Molecular Formula | — |
| Molecular Weight | — |
Product Information
4'-O-2,6-Dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl Selamectin
4'-O-2,6-Dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl Selamectin (CAS 301849-46-7) product identity, structure identifiers and related reaction data for chemical intermediate research and sourcing review.
CAS Number301849-46-7
Database ID131637883
Molecular Formula—
Updated2026-10-16
Potential Applications
Potential Applications
For professional research and industrial use only
Database ID 131637883
Computed Properties
Exact Mass—
XLogP—
Topological Polar Surface Area—
Hydrogen Bond Donors—
Hydrogen Bond Acceptors—
Rotatable Bonds—
- IUPAC Name
- —
- InChIKey
- —
- SMILES
- C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)CC=C([C@H]([C@H](C=CC=C4CO[C@H]\5[C@@]4([C@@H](C=C(/C5=N\O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)C)O[C@@H]1C8CCCCC8
- InChI
- —
Safety Notice
Safety & Notes
For professional research and industrial use only. Review the supplier safety data sheet before handling.
PubChem References
Public References
These sources are listed in the compound's public database record.
Request a Quote
Need this intermediate?
Send the required specification, quantity, destination and intended use. The CATO team will review availability and respond.
CAS 301849-46-74'-O-2,6-Dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl Selamectin
Complete inquiry